Monika Marcinkowska

2 Seguidores

4 SlideShares 2 Seguidores 5 Siguiendos

4 SlideShares 2 Seguidores 5 Siguiendos

obesity α2-adrenergic receptor antiobesity drug d2 partial agonis ssri depression mood disorders sert d1 receptor antipsychotics virtual screening new antipsychotics zolpidem 5-ht6 antagonist d2 partial agonist behavioural and physiological symptoms of dementia

Ver más

Actividad
Acerca de

5-HT6 antagonist/D2 partial agonist targeting behavioural and psychological symptoms of dementia

Hace 9 años • 1121 Visualizaciones

Virtual screening studies in search of dopamine D1 receptor ligands as antipsychotic agents

Hace 9 años • 589 Visualizaciones

Novel ligands acting as SERT blockers and dopamine D2 receptor partial agonists with therapeutic potential for treatment of mood disorders and their comorbidities

Hace 9 años • 352 Visualizaciones

New ligands of α2-adrenergic receptor with a potential anti-obesity activity

Hace 9 años • 308 Visualizaciones

obesity α2-adrenergic receptor antiobesity drug d2 partial agonis ssri depression mood disorders sert d1 receptor antipsychotics virtual screening new antipsychotics zolpidem 5-ht6 antagonist d2 partial agonist behavioural and physiological symptoms of dementia

Ver más